Section

Japan’s Otsuka Pharma gets US FDA approval for Alzheimer’s agitation drug

2 years ago Philippines inquirer

A PHP Error was encountered

Severity: Warning

Message: getimagesize(https://newsinfo.inquirer.net/files/2023/05/US-FDA-300x200.jpg): Failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden

Filename: views/amp_news_detail.php

Line Number: 138

Backtrace:

File: /home/moneynations/public_html/application/views/amp_news_detail.php
Line: 138
Function: getimagesize

File: /home/moneynations/public_html/application/controllers/News.php
Line: 132
Function: view

File: /home/moneynations/public_html/index.php
Line: 291
Function: require_once

The U.S. Food and Drug Administration approved Otsuka Pharmaceutical’s brexpiprazole to treat agitation in patients with Alzheimer’s on Thursday, making it the first approved drug for the indication, the company said in a statement. The decision comes after an advisory panel in April voted 9-1 that the company had enough data to identify the population […]

The post Japan’s Otsuka Pharma gets US FDA approval for Alzheimer’s agitation drug appeared first on Inquirer News.

Read more at: inquirer

Tags : japan otsuka pharma approval alzheimer agitation

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Bollywood charcha does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.

You May Also Like